Surface Glycoproteins of Exosomes Shed by Myeloid-Derived Suppressor Cells Contribute to Function

Journal of Proteome Research

Volumn 16, Issue 1, 2017, Pages 238-246

  Chauhan, Sitara ^a   Danielson, Steven ^b   Clements, Virginia ^c   Edwards, Nathan ^d   Ostrand Rosenberg, Suzanne ^c   Fenselau, Catherine ^a  

^a Bldg 142   (United States)

^b Thermo Fisher Scientific   (United States)

^c UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cell surface capture; exosomes; myeloid derived suppressor cells; N glycoproteome

Indexed keywords

BETA1 INTEGRIN; CD11B ANTIGEN; CD157 ANTIGEN; CD172A ANTIGEN; CD177 ANTIGEN; CD18 ANTIGEN; CD39 ANTIGEN; CD4 ANTIGEN; CD47 ANTIGEN; CD82 ANTIGEN; CD97 ANTIGEN; CELL SURFACE PROTEIN; ENDOTHELIAL LIPASE; FIBRINOGEN RECEPTOR; FIBRONECTIN; GALECTIN 3; HERMES ANTIGEN; INTERLEUKIN 1BETA; JUNCTIONAL ADHESION MOLECULE A; KERATIN TYPE II CYTOSKELETAL 1B; MAST CELL EXPRESSED MEMBRANE PROTEIN 1; MEMBRANE PROTEIN; MYELOPEROXIDASE; OLFACTOMEDIN 4; PEPTIDES AND PROTEINS; REGULATOR PROTEIN; SIGNAL REGULATORY PROTEIN ALPHA; T LYMPHOCYTE RECEPTOR; THROMBOSPONDIN 1; TRANSMEMBRANE 9 SUPERFAMILY MEMBER 3; UNCLASSIFIED DRUG; CD47 PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR; PROTEOME; PTPNS1 PROTEIN, MOUSE; THROMBOSPONDIN-1, MOUSE;

ALKYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL SURFACE; CENTRIFUGATION; CHEMOTAXIS; CONTROLLED STUDY; EXOSOME; EXTRACELLULAR SPACE; FEMALE; FLOW CYTOMETRY; GLYCOSYLATION; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MOUSE; MYELOID-DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; SURFACE PROPERTY; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; EXPERIMENTAL MAMMARY NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; UDDER;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD47; CHEMOTAXIS; EXOSOMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MYELOID-DERIVED SUPPRESSOR CELLS; PROTEOME; RECEPTORS, IMMUNOLOGIC; THROMBOSPONDIN 1;

EID: 85009877249     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.6b00811     Document Type: Article

References (61)

1. Tseng, D.; Volkmer, J.-P.; Willingham, S. B.; Contreras-Trujillo, H.; Fathman, J. W.; Fernhoff, N. B.; Seita, J.; Inlay, M. A.; Weiskopf, K.; Miyanishi, M. et al. Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response Proc. Natl. Acad. Sci. U. S. A. 2013, 110, 11103-11108 10.1073/pnas.1305569110
2. Unanue, E. R. Perspectives on anti-CD47 antibody treatment for experimental cancer Proc. Natl. Acad. Sci. U. S. A. 2013, 110, 10886-10887 10.1073/pnas.1308463110
3. Sun, B.; Hood, L. Protein-Centric N-Glycoproteomics Analysis of Membrane and Plasma Membrane Proteins J. Proteomics Res. 2014, 13, 2705-2714 10.1021/pr500187g
4. Bock, T.; Moest, H.; Omasits, U.; Dolski, S.; Lundberg, E.; Frei, A.; Hofmann, A.; Bausch-Fluck, D.; Jacobs, A.; Krayenbuehl, N. et al. Proteomic analysis reveals drug accessible cell surface N-glycoproteins of primary and established glioblastoma cell lines J. Proteome Res. 2012, 11, 4885-4893 10.1021/pr300360a
5. Mathivanan, S.; Ji, H.; Simpson, R. J. Exosomes: Extracellular organelles important in intercellular communication J. Proteomics 2010, 73, 1907-1920 10.1016/j.jprot.2010.06.006
6. Kowal, J.; Arras, G.; Colombo, M.; Jouve, M.; Morath, J. P.; Primdal-bengtson, B. et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes Proc. Natl. Acad. Sci. U. S. A. 2016, 113, E968-E977 10.1073/pnas.1521230113
7. Andreu, Z.; Yáñez-Mó, M. Tetraspanins in extracellular vesicle formation and function Front. Immunol. 2014, 5, 442 10.3389/fimmu.2014.00442
8. Heijnen, B. H. F. G.; Schiel, A. E.; Fijnheer, R.; Geuze, H. J.; Sixma, J. J. Activated Platelets Release Two Types of Membrane Vesicles Blood J. 1999, 94, 3791-3800
9. Bellingham, S. A.; Guo, B. B.; Coleman, B. M.; Hill, A. F. Exosomes: Vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? Front. Physiol. 2012, 3, 124 10.3389/fphys.2012.00124
10. Chahar, H.; Bao, X.; Casola, A. Exosomes and Their Role in the Life Cycle and Pathogenesis of RNA Viruses Viruses 2015, 7, 3204-3225 10.3390/v7062770
11. Hoshino, A.; Costa-Silva, B.; Shen, T.-L.; Rodrigues, G.; Hashimoto, A.; Tesic Mark, M.; Molina, H.; Kohsaka, S.; Di Giannatale, A.; Ceder, S. et al. Tumour exosome integrins determine organotropic metastasis Nature 2015, 527, 329-335 10.1038/nature15756
12. 6 integrin is transferred intercellularly via exosomes J. Biol. Chem. 2015, 290, 4545-4551 10.1074/jbc.C114.617662
13. Marvel, D.; Gabrilovich, D. I. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected J. Clin. Invest. 2015, 125, 3356-3364 10.1172/JCI80005
14. Parker, K. H.; Beury, D. W.; Ostrand-rosenberg, S. Myeloid- Deived Suppressor Cells: Critical cells driving Immune Suppression in the Tumor Microenvironment Adv. Cancer Res. 2015, 128, 95-139 10.1016/bs.acr.2015.04.002
15. Ostrand-Rosenberg, S.; Sinha, P. et al. Myeloid-derived suppressor cells: linking inflammation and cancer J. Immunol. 2009, 182, 4499-4506 10.4049/jimmunol.0802740
16. Sinha, P.; Clements, V. K.; Fulton, A. M.; Ostrand-Rosenberg, S. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells Cancer Res. 2007, 67, 4507-4513 10.1158/0008-5472.CAN-06-4174
17. Parker, K. H.; Sinha, P.; Horn, L. A.; Clements, V. K.; Yang, H.; Li, J.; Tracey, K. J.; Ostrand-Rosenberg, S. HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells Cancer Res. 2014, 74, 5723-5733 10.1158/0008-5472.CAN-13-2347
18. Xiang, X.; Poliakov, A.; Liu, C.; Liu, Y.; Deng, Z.; Wang, J.; Cheng, Z.; Shah, S. V.; Wang, G.-J.; Zhang, L. et al. Induction of myeloid-derived suppressor cells by tumor exosomes Int. J. Cancer 2009, 124, 2621-2633 10.1002/ijc.24249
19. Yang, C.; Robbins, P. D. The roles of tumor-derived exosomes in cancer pathogenesis Clin. Dev. Immunol. 2011, 2011, 842849 10.1155/2011/842849
20. Burke, M.; Choksawangkarn, W.; Edwards, N.; Ostrand-Rosenberg, S.; Fenselau, C. Exosomes from Myeloid-Derived Suppressor Cells Carry Biologically Active Proteins J. Proteome Res. 2014, 13 (2) 836-843 10.1021/pr400879c
21. Sinha, P.; Okoro, C.; Foell, D.; Freeze, H. H.; Ostrand-Rosenberg, S.; Srikrishna, G. Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells J. Immunol. 2008, 181, 4666-4675 10.4049/jimmunol.181.7.4666
22. Ghosh, D.; Krokhin, O.; Antonovici, M.; Ens, W.; Standing, K. G.; Beavis, R. C.; Wilkins, J. A. Lectin Affinity as an Approach to the Proteomic Analysis of Membrane Glycoproteins research articles J. Proteome Res. 2004, 3, 841-850 10.1021/pr049937f
23. Rybak, J.-N.; Scheurer, S. B.; Neri, D.; Elia, G. Purification of biotinylated proteins on streptavidin resin: a protocol for quantitative elution Proteomics 2004, 4, 2296-2299 10.1002/pmic.200300780
24. Shin, B. K.; Wang, H.; Yim, A. M.; Le Naour, F.; Brichory, F.; Jang, J. H.; Zhao, R.; Puravs, E.; Tra, J.; Michael, C. W. et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function J. Biol. Chem. 2003, 278, 7607-7616 10.1074/jbc.M210455200
25. Choksawangkarn, W.; Kim, S.; Cannon, J. R.; Edwards, N. J.; Lee, S. B.; Fenselau, C. Enrichment of Plasma Membrane Proteins Using Nanoparticle Pellicles: Comparison between Silica and Higher Density Nanoparticles J. Proteome. Res. 2013, 12, 1134-1141 10.1021/pr301107x
26. Elschenbroich, S.; Kim, Y.; Medin, J. a; Kislinger, T. Isolation of cell surface proteins for mass spectrometry-based proteomics Expert Rev. Proteomics 2010, 7, 141-154 10.1586/epr.09.97
27. Boeggeman, E.; Ramakrishnan, B.; Kilgore, C.; Khidekel, N.; Hsieh-Wilson, L. C.; Simpson, J. T.; Qasba, P. K. Direct identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic method Bioconjugate Chem. 2007, 18, 806-814 10.1021/bc060341n
28. Ramya, T. N. C.; Weerapana, E.; Cravatt, B. F.; Paulson, J. C. Glycoproteomics enabled by tagging sialic acid- or galactose-terminated glycans Glycobiology 2013, 23, 211-221 10.1093/glycob/cws144
29. Gundry, R. L.; Raginski, K.; Tarasova, Y.; Tchernyshyov, I.; Bausch-Fluck, D.; Elliott, S. T.; Boheler, K. R.; Van Eyk, J. E.; Wollscheid, B. The mouse C2C12 myoblast cell surface N-linked glycoproteome: identification, glycosite occupancy, and membrane orientation Mol. Cell. Proteomics 2009, 8, 2555-2569 10.1074/mcp.M900195-MCP200
30. Zhang, H.; Li, X.-J.; Martin, D. B.; Aebersold, R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry Nat. Biotechnol. 2003, 21, 660-666 10.1038/nbt827
31. Weekes, M. P.; Antrobus, R.; Lill, J. R.; Duncan, L. M.; Hör, S.; Lehner, P. J. Comparative analysis of techniques to purify plasma membrane proteins J. Biomol. Technol. 2010, 21, 108-115
32. Chornoguz, O.; Grmai, L.; Sinha, P.; Artemenko, K. A.; Zubarev, R. A.; Ostrand-Rosenberg, S. Proteomic pathway analysis reveals inflammation increases myeloid-derived suppressor cell resistance to apoptosis Mol. Cell. Proteomics 2011, 10, M110.002980 10.1074/mcp.M110.002980
33. Kessner, D.; Chambers, M.; Burke, R.; Agus, D.; Mallick, P. ProteoWizard: open source software for rapid proteomics tools development Bioinformatics 2008, 24, 2534-2536 10.1093/bioinformatics/btn323
34. Edwards, N. J. PepArML: A Meta-Search Peptide Identification Platform for Tandem Mass Spectra Curr. Protoc Bioinformatics 2013, 13.23.1 10.1002/0471250953.bi1323s44
35. Kim, S.; Pevzner, P. A. MS-GF+ makes progress towards a universal database search tool for proteomics Nat. Commun. 2014, 5, 5277 10.1038/ncomms6277
36. Gundry, R. L.; Riordon, D. R.; Tarasova, Y.; Chuppa, S.; Juhasz, O.; Wiedemeier, O.; Milanovich, S.; Noto, F. K.; Tchernyshyov, I.; Raginski, K. et al. A Cell Surfaceome Map for Immunophenotyping and Sorting Pluripotent Stem Cells Mol. Cell. Proteomics 2012, 11, 303 10.1074/mcp.M112.018135
37. Gupta, R.; Brunak, S. Prediction of glycosylation across the human proteome and the correlation to protein function Pac. Symp. Biocomput. 2002, 322, 310-322 10.1142/9789812799623-0029
38. Omasits, U.; Ahrens, C. H.; Muller, S.; Wollscheid, B. Protter: interactive protein feature visualization and integration with experimental proteomic data Bioinformatics 2014, 30, 884-886 10.1093/bioinformatics/btt607
39. Ung, T. H.; Madsen, H. J.; Hellwinkel, J. E.; Lencioni, A. M.; Graner, M. W. Exosome proteomics reveals transcriptional regulator proteins with potential to mediate downstream pathways Cancer Sci. 2014, 105, 1384-1392 10.1111/cas.12534
40. Bausch-Fluck, D.; Hofmann, A.; Bock, T.; Frei, A. P.; Cerciello, F.; Jacobs, A.; Moest, H.; Omasits, U.; Gundry, R. L.; Yoon, C. et al. A mass spectrometric-derived cell surface protein atlas PLoS One 2015, 10, e0121314 10.1371/journal.pone.0121314
41. Lv, Z.; Bian, Z.; Shi, L.; Niu, S.; Ha, B.; Tremblay, A.; Li, L.; Zhang, X.; Paluszynski, J.; Liu, M. et al. Loss of Cell Surface CD47 Clustering Formation and Binding Avidity to SIRPα Facilitate Apoptotic Cell Clearance by Macrophages J. Immunol. 2015, 195, 661-671 10.4049/jimmunol.1401719
42. Nagira, M.; Imai, T.; Ishikawa, I.; Uwabe, K.-I.; Yoshie, O. Mouse Homologue of C33 Antigen (CD82), a member of the transmembrane 4 superfamily: Complementary DNA, genomic structure, and expression Cell. Immunol. 1994, 157, 144-157 10.1006/cimm.1994.1212
43. Valadi, H.; Ekström, K.; Bossios, A.; Sjöstrand, M.; Lee, J. J.; Lötvall, J. O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat. Cell Biol. 2007, 9, 654-659 10.1038/ncb1596
44. Taylor, D. D.; Gercel-Taylor, C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer Gynecol. Oncol. 2008, 110, 13-21 10.1016/j.ygyno.2008.04.033
45. Rabinowits, G.; Gerçel-Taylor, C.; Day, J. M.; Taylor, D. D.; Kloecker, G. H. Exosomal microRNA: a diagnostic marker for lung cancer Clin. Lung Cancer 2009, 10, 42-46 10.3816/CLC.2009.n.006
46. Segura, E.; Guerin, C.; Hogg, N.; Amigorena, S.; Thery, C. CD8+ Dendritic Cells Use LFA-1 to Capture MHC-Peptide Complexes from Exosomes In Vivo J. Immunol. 2007, 179, 1489-1496 10.4049/jimmunol.179.3.1489
47. Clayton, A.; Mitchell, J. P.; Court, J.; Linnane, S.; Mason, M. D.; Tabi, Z. Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression J. Immunol. 2008, 180, 7249-7258 10.4049/jimmunol.180.11.7249
48. Clayton, A.; Turkes, A.; Dewitt, S.; Steadman, R.; Mason, M. D.; Hallett, M. B. Adhesion and signaling by B cell-derived exosomes: the role of integrins FASEB J. 2004, 18 (9) 977-979 10.1096/fj.03-1094fje
49. Feng, D.; Zhao, W. L.; Ye, Y. Y.; Bai, X. C.; Liu, R. Q.; Chang, L. F.; Zhou, Q.; Sui, S. F. Cellular internalization of exosomes occurs through phagocytosis Traffic 2010, 11, 675-687 10.1111/j.1600-0854.2010.01041.x
50. Singh, R.; Pochampally, R.; Watabe, K.; Lu, Z.; Mo, Y.-Y. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer Mol. Cancer 2014, 13, 256 10.1186/1476-4598-13-256
51. Fujimoto, T. T.; Katsutani, S.; Shimomura, T.; Fujimura, K. Thrombospondin-bound integrin-associated protein (CD47) physically and functionally modifies integrin αIIbβ3 by its extracellular domain J. Biol. Chem. 2003, 278, 26655-26665 10.1074/jbc.M302194200
52. Jalkanen, S.; Jalkanen, M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin J. Cell Biol. 1992, 116, 817-825 10.1083/jcb.116.3.817
53. Short, S. M.; Derrien, A.; Narsimhan, R. P.; Lawler, J.; Ingber, D. E.; Zetter, B. R. Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by beta1 integrins J. Cell Biol. 2005, 168, 643-653 10.1083/jcb.200407060
54. Smiley, S. T.; King, J. A.; Hancock, W. W. Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 4 J. Immunol. 2001, 167, 2887-2894 10.4049/jimmunol.167.5.2887
55. Poncz, M.; Eisman, R.; Heidenreich, R.; Silver, S. M.; Vilaire, G.; Surrey, S.; Schwartz, E.; Bennett, J. S. Structure of the platelet membrane glycoprotein IIb J. Biol. Chem. 1987, 262, 8476-8482
56. Moroi, M.; Jung, S. M. A mechanism to safeguard platelet adhesion under high shear flow: Von Willebrand factor-glycoprotein Ib and integrin α2 β1-collagen interactions make complementary, collagen-type-specific contributions to adhesion J. Thromb. Haemostasis 2007, 5, 797-803 10.1111/j.1538-7836.2007.02439.x
57. Saumet, A.; Legrand, C.; Dubernard, V.; de Jesus, N. Association of thrombospondin-1 with the actin cytoskeleton of human thrombin-activated platelets through an αIIbβ3- or CD36-independent mechanism mechanism Biochem. J. 2002, 363, 473-482 10.1042/bj3630473
58. El Ghmati, S. M.; Van Hoeyveld, E. M.; Van Strijp, J. G.; Ceuppens, J. L.; Stevens, E. A. Identification of haptoglobin as an alternative ligand for CD11b/CD18 J. Immunol. 1996, 156, 2542-2552
59. Rubel, C.; Gómez, S.; Fernández, G. C.; Isturiz, M. A.; Caamaño, J.; Palermo, M. S. Fibrinogen-CD11b/CD18 interaction activates the NF-κB pathway and delays apoptosis in human neutrophils Eur. J. Immunol. 2003, 33, 1429-1438 10.1002/eji.200323512
60. Rebres, R. A.; Kajihara, K.; Brown, E. J. Novel CD47-dependent intercellular adhesion modulates cell migration J. Cell. Physiol. 2005, 205, 182-193 10.1002/jcp.20379
61. Oxford University, Stanford University. CAMELLIA: Anti-CD47 Antibody Therapy in Relapsed/Refractory Acute Myeloid Leukaemia. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2016- [cited 2016 Aug 22]. Available from: https://clinicaltrials.gov/ct2/show/NCT02678338?term=CD47&rank=1.